Before I rant I’ll just say the 10q is somewhat pointless
Before I rant I’ll just say the 10q is somewhat pointless when it comes to the future Cytodyn. Even though I’ve read it twice today. I know this statement by itself will make many bashers and their small heads explode. Anyways that’s a different story. To answer the question, go to the last paragraph or feel free to read the entire thing.
“As of November 30, 2022, we had approximately 262.2 million unreserved authorized shares of common stock available for issuance. Our ability to continue to fund our operations depends on our ability to raise capital”
Operating expenses have been 15 million the past 6 months from the previous 45 million.
Cyrus is asking for 15 million from private investors. We have 262.2 million right now of the 350 million as of Nov 30th, 2022.
Now at the current share price, we would need approximately 68 million shares give or take a few pennies to get us to 15 million. Now at this price I’m assuming it would be at a discount so anything is possible could be as high as 100 million @ .15 cents a share. Does this mean anything short term ? Maybe, depends what is taking place behind close doors. Seems like we just need to keep the lights on for now.
So with that being said I think Cyrus will get the 15 million even if he gets .15 cents per share. I don’t think he can wait on any news because we need cash to pay Dr Welch in a week and we are so anxiously awaiting the hold to be lifted before any other news takes place imo.
Now I still think we have been doing these raises just to buy us time until the “infliction point for investors happens”. Whenever and whatever that might be, let’s just say I think these fire sales private placements are coming to an end very soon..
I think something much bigger is going on here. Kinda like MGK has been stating. Which makes the 15 million a moot point along with all the other stuff we are all worried about right now. Yes dilution sucks and I hope the bleeding stops. Now that I think about it I’m writing like MGK tonight. Hopefully people read this !!!!
So anyways…. Short answer, anywhere from 1 million shares to 150 million shares is my guess because nobody knows what the share price will be tomorrow. Not even Cyrus technically, because the hold can be lifted any day now and that alone changes a lot of things!!!!
I mean we are after all sitting on the cure for HIV. Can we really put a price on that.
10
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Legal Storms Brewing for Honeywell Aerospace Well, stock aces, here's a curveball for anyone with a stake in Honeywell Aerospace Inc. (NASDAQ: HONA). The DJS Law Group tossed a legal grenade right into the heart of Honeywell's operations. Allegations fly that the company's been playing fast and loose with the truth during its supply chain saga. The Heart of the Allegation...
Continue Reading
Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...
Continue Reading
Understanding the Challenges of Selling Montana Cabins When folks think about selling real estate, the logistics of marketing quaint Montana cabins or lifestyle properties can be different than your typical city apartment. In the wide-open spaces of places like Libby, Montana, seller needs aren't just about showing a property—it's about telling a story. Shawna Norry, an...
Continue Reading
The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...
Continue Reading
Platform Accounting's Bold Expansion Move When you hear about a $355 million strategic financing round, it paints a picture of company ambitions colored in big, bold strokes. Platform Accounting Group (PAG) has managed to secure such a hefty financial backing from Treville Capital Group, taking a serious shot at expanding its footprint and offerings. This is no small...
Continue Reading
Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...
Continue Reading
Bolstering Educational Support for Low-Income Students In a world where opportunities hang on the thread of education, Tutoring America stands as a beacon for those left behind. This nonprofit tackles the education gap head-on, aiming to uplift low-income kids before they hit high school turbulence. Frankly, what they're doing is more than just good work—it's laying the...
Continue Reading
Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....
Continue Reading
Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...
Continue Reading
Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming a Decade of Investment: The Ensign Group Journey Ensign Group (NASDAQ: ENSG) has shown a remarkable performance over the last decade, surpassing the market with an impressive annualized growth rate of 12.64%. This extraordinary growth results in an average annual return of 23.92%, highlighting the potential benefits of long-term investments. Significance of a...
Continue Reading
Join CommunityRewards™ for a Unique Charity Event CommunityRewards™ is excited to announce its partnership with 305 Pink Pack for an inspiring fundraising event. Together, they will host a special night at the Miami Heat vs. Atlanta Hawks NBA game, celebrating local community efforts to support women battling cancer. This event will take place at the Kaseya Center,...
Continue Reading
In the ever-shifting dance of fund management, Aberdeen Multi-Market Income Fund is taking some bold new steps. If you're holding some shares of NYSE:MMT, you're about to see a plumped-up distribution check thanks to a hefty 22% increase in monthly payouts. But is this move pure bravado or a calculated masterstroke? Mood Shift: Managed Distribution Policy Kicks In The...
Continue Reading
Ryan Specialty Prices $600 Million in Senior Secured Notes Ryan Specialty Holdings, Inc. (NYSE: RYAN) is making headlines with its recent announcement regarding the pricing of an impressive $600 million aggregate principal amount of senior secured notes. This comes as a significant initiative by Ryan Specialty, LLC, an indirect subsidiary of the company, aimed at...
Continue Reading
Pied Piper Foundation Joins CBTN Executive Council The Children's Brain Tumor Network (CBTN) is pleased to announce a new strategic partnership with the Pied Piper Foundation, which has recently joined the Executive Council. This collaboration brings together CBTN's expertise in childhood brain cancer research and the Pied Piper Foundation's strengths in fundraising and...
Continue Reading